273 related articles for article (PubMed ID: 28703809)
1. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
3. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.
Schmitt NC; Rubel EW; Nathanson NM
J Neurosci; 2009 Mar; 29(12):3843-51. PubMed ID: 19321781
[TBL] [Abstract][Full Text] [Related]
6. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
7. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
[TBL] [Abstract][Full Text] [Related]
8. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3.
Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q
Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757
[TBL] [Abstract][Full Text] [Related]
9. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
[TBL] [Abstract][Full Text] [Related]
10. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
Yuan CH; Horng CT; Lee CF; Chiang NN; Tsai FJ; Lu CC; Chiang JH; Hsu YM; Yang JS; Chen FA
Environ Toxicol; 2017 Mar; 32(3):845-855. PubMed ID: 27200496
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
13. Protective Role of Epigallocatechin Gallate in a Rat Model of Cisplatin-Induced Cerebral Inflammation and Oxidative Damage: Impact of Modulating NF-κB and Nrf2.
Arafa MH; Atteia HH
Neurotox Res; 2020 Feb; 37(2):380-396. PubMed ID: 31410684
[TBL] [Abstract][Full Text] [Related]
14. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cisplatin-induced ototoxicity and prevention.
Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
[TBL] [Abstract][Full Text] [Related]
16. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
17. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
19. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.
Jamesdaniel S; Coling D; Hinduja S; Ding D; Li J; Cassidy L; Seigel GM; Qu J; Salvi R
J Biol Chem; 2012 May; 287(22):18674-86. PubMed ID: 22493493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]